Stock exchange intimation

Stock Exchange Intimation

Filter:

12 Feb 2026 – Intimation of ESG Rating by SES ESG Research Private Limited
11 Feb 2026 – OneSource-Hikma partnership secures approval to commercialise generic version of Ozempic in Saudi Arabia
30 Jan 2026 – Transcript of Earnings Call pertaining to unaudited Financial Results of the Company for the quarter ended December 31, 2025
28 Jan 2026 – Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011 And Regulation 7(2) Of SEBI (PIT) Regulations, 2015
25 Jan 2026 – Newspaper advertisement – Unaudited financial results of the Company for the quarter ended December 31, 2025
24 Jan 2026 – Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended December 31, 2025
24 Jan 2026 – Addendum to press release (In the previous intimation made (i.e. only in the subject line while submitting to the exchange),the date of the original press release submission was mentioned as January 23, 2025 instead of January 23, 2026)
24 Jan 2026 – Addendum to press release (original press release dated January 23, 2026)
23 Jan 2026 – Intimation of the Earnings Presentation (along with Press Release) for the Q3 of FY 2025-26
23 Jan 2026 – SEI_Outcome of the Board meeting approving the unaudited financial results for the quarter ended December 31, 2025
21 Jan 2026 – Intimation of Allotment of Equity shares under OneSource Specialty Pharma Limited – Employee Stock Option Plan 2021
19 Jan 2026 – Disclosure Regulation 29(1) of SEBI (SAST) Regulation for Catalyst Trusteeship Ltd
19 Jan 2026 – Amalgamation of Stelis Pte Limited with OneSource Specialty Pte Limited, wholly owned subsidiaries of OneSource India
19 Jan 2026 – Intimation of The Board Meeting for Approval of Unaudited Financial Results for Quarter ended December 31, 2025
19 Jan 2026 – Earnings Call to discuss unaudited financial results of the Company for the quarter ended December 2025